Lara Kevorkian

Title: The Innovative Contributions of Lara Kevorkian

Introduction

Lara Kevorkian is a prominent inventor based in Slough, GB, known for her significant contributions to the field of biotechnology. With a total of seven patents to her name, she has made remarkable advancements in therapeutic antibodies and their applications in treating various diseases.

Latest Patents

Among her latest patents, Lara has developed Anti-FcRn antibodies, which are specific to FcRn. This patent includes formulations comprising these antibodies, their therapeutic uses, processes for expressing and formulating the antibodies, as well as the DNA encoding these antibodies and the host cells that comprise said DNA. Additionally, she has worked on antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3, focusing on their use for the treatment of lung fibrosis. This patent encompasses TGF-beta antibodies, binding fragments, DNA encoding these antibodies, and methods for expressing them in host cells. Furthermore, it extends to pharmaceutical compositions that include these antibodies and their use in treating various diseases, including fibrosis.

Career Highlights

Lara has had a successful career, working with notable companies such as UCB Biopharma Srl and UCB Biopharma Sprl. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of biopharmaceuticals.

Collaborations

Throughout her career, Lara has collaborated with esteemed colleagues, including Kerry Louise Tyson and Helene Margaret Finney. These collaborations have further enriched her research and innovation efforts.

Conclusion

Lara Kevorkian's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases her dedication to advancing medical science. Her contributions have the potential to significantly impact the treatment of various diseases, highlighting her importance as an inventor in the industry.